Global Beri Beri Treatment Market, By Type (Dry Beri Beri, Wet Beri Beri), Cause (Thiamine Deficiency, Alcohol Use Disorder, Genetic), Drug Type (Branded, Generic), Route of Administration (Oral, Injectable), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.
Beri Beri Treatment Market Analysis and Size
Beri beri is a rare disease caused by the nutritional deficiency of vitamin B1 or thiamine. As per recent research, this disorder is very rare in the U.S. This is because all the food is vitamin enriched. The disease can be witnessed in women suffering from vomiting in pregnancy, extreme nausea, people suffering from AIDS. The treatment of beri beri is very natural.
Data Bridge Market Research analyses a growth rate in the beri beri treatment market in the forecast period 2023-2030. The expected CAGR of beri beri treatment market is tend to be around 14% in the mentioned forecast period. The market value is USD 211 million in 2022, and it would grow up to USD 601.9 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Beri Beri Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Dry Beri Beri, Wet Beri Beri), Cause (Thiamine Deficiency, Alcohol Use Disorder, Genetic), Drug Type (Branded, Generic), Route of Administration (Oral, Injectable, End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GSK Plc. (U.K.), Bayer AG (Germany), Novartis AG (Switzerland), Mylan N.V. (U.S.), AvKARE, LLC (U.S.), Fresenius Kabi USA (U.S.), Franco- aurochem (India), Leben Laboratories Pvt. Ltd (India), regardiapharma (India), Synokem Pharmaceuticals Ltd. (India), Nutricost (U.S.), Solgar Inc. (U.S.), Nature's Way Products, LLC (U.S.), Swanson (U.S.), EZ Melts (Florida), BulkSupplements (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Beri Beri is caused because of a vitamin deficiency of vitamin B-1. It can be life-threatening if left untreated. A kind of beri beri known as wet beri beri affects both the circulatory system and heart, on the other hand, dry beri beri leads to damage to nerves and a decline in muscle strength and may cause muscle paralysis in severe cases. The breastfed infants suffering from Vitamin B1 deficiency suffer from this condition. Furthermore, dialysis and heavy doses of water pills increase the beriberi risk.
Beri Beri Treatment Market Dynamics
Drivers
- Rising Diagnostic Procedures
There are certain physical examinations and other medical tests used to determine whether a person is suffering from beriberi. The test includes breathing and lung functioning tests. Blood and urine tests to check the levels of thiamine in the blood cells, physical examination of the legs to know if any swelling occurs in both the lower legs, heart examination is performed to check the variations in the heartbeat and the enlargement of the heart. Then neurological examination to check for the changes in coordination problems, walking, decreased reflexes is also performed. This boosts the market growth.
Opportunities
- Increased Demand of Wet Beri-beri
Thiamine deficiency with CVD disease is known as wet beriberi. Peripheral vasodilation develops in the first stage, leading to a high cardiac output state. This leads to salt and water retention in the kidneys, controlled by the renin-angiotensin-aldosterone system. The kidneys identify a relative volume loss as the vasodilation progresses and respond by conserving salt. Fluid is absorbed into the circulatory system as a result of salt retention. Edema of the dependent extremities happens due to fluid overload. Additionally, vitamin B1 therapy can help diagnose and treat wet beriberi. It is extensively accepted that patients doubted of having thiamine deficiency should receive therapeutic thiamine administration. Thus, the wet beri beri patients demand increased treatment processes and thus boosts the market growth.
Restraints/Challenges
- High Cost of Treatment
The enormous expenditure required for the treatment processes impedes the market growth. Several market players make huge investments in manufacturing new and advanced treatment procedures to improve the recovery process, and in return, the cost is increased.
This beri beri treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the beri beri treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Beri Beri Treatment Market Scope
The beri beri treatment market is segmented on the basis of type, cause, drug type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Dry Beri Beri
- Wet Beri Beri
Cause
- Thiamine Deficiency
- Alcohol Use Disorder
- Genetic
Drug Type
- Branded
- Generic
Route of Administration
- Oral
- Injectable
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Beri Beri Treatment Regional Analysis/Insights
The beri beri treatment market is analyzed and market size insights and trends are provided by type, cause, drug type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the beri beri treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market in the forecast period because of the high healthcare expenditure and good quality medical facilities combined with the majority of the population having insurance cover to claim this type of expensive treatment.
Asia-Pacific is considered to grow over the coming years due to increasing awareness among the people. Furthermore, countries such as India, China are contributing to the immense market growth due to the supportive funds and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Beri beri Treatment Share Analysis
The beri beri treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to beri beri treatment market
Key players operating in the beri beri treatment market include:
- GSK Plc. (U.K.)
- Bayer AG (Germany)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- AvKARE, LLC (U.S.)
- Fresenius Kabi USA (U.S.)
- Franco- aurochem (India)
- Leben Laboratories Pvt. Ltd (India)
- regardiapharma (India)
- Synokem Pharmaceuticals Ltd. (India)
- Nutricost (U.S.)
- Solgar Inc. (U.S.)
- Nature's Way Products, LLC (U.S.)
- Swanson (U.S.)
- EZ Melts (Florida)
- BulkSupplements (U.S.)
SKU-